Διοικητικό Συμβούλιο

Η LEO Pharma διοικείται εξ’ ολοκλήρου από το Ίδρυμα LEO. Το Διοικητικό Συμβούλιο του Ιδρύματος LEO είναι αφοσιωμένο στη μακροχρόνια επιτυχία της LEO Pharma και υποστηρίζει τις αξίες του οράματος και της αποστολής της εταιρείας

Διοικητικό συμβούλιο της LEO Pharma Α/S

  • Catherine Mazzacco, President and CEO

  • Anders Kronborg, Executive Vice President, Global Finance & Business Services

  • Chris Posner, Executive Vice President, US and President & CEO of LEO Pharma, Inc.

  • Guillaume Clément, Executive Vice President, Region Europe+

  • Jørgen Damsbo Andersen, Executive Vice President, Region International

  • Kim Kjøller, Executive Vice President, Global Research & Development

  • Mette Vestergaard, Executive Vice President, Global People & Business Transformation

  • Patrice Baudry, Executive Vice President, Global Marketing, Market Access & Medical Affairs

  • Rhonda Duffy, Executive Vice President, Global Product Supply

Διοικητικό Συμβούλιο του Ιδρύματος LEO 

  • Lars Olsen, Chairman of the Board, MD, MBA

  • Eivind Kolding, Vice chairman of the Board, MA Law, admitted to the Danish High Court

  • Allan Carsten Dahl, Employee elected Board member, MSc Chemistry, PhD

  • Cristina Lage, Board member, MSc Economics

  • Anja Boisen, Board member, Professor at DTU Health Technology, Director of DNRF and Villum Centre of Excellence ‘IDUN’

  • Karin Jexner Hamberg, Board member, Senior Vice President, Medical & Regulatory Science, H. Lundbeck A/S, Denmark, MD

  • Jannie Kogsbøll, Employee elected Board member, Process Assistant

  • Lars Green, Board member, CFO & Executive Vice President, Finance, IT & Legal, Novozymes A/S

  • Lars Kjøller, Employee elected Board member, MSc (Library & Information Science), PhD (Molecular Biology)

  • Lotte Hjortshøj Larsen, Employee elected Board member, Diploma Graduate

  • Dr Peter Schwarz, Board member, Professor, MD, DMSci, Department of Endocrinology, Rigshospitalet & Institute of Clinical Medicine, Copenhagen University